Most just lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar spots as classical opioid receptors, it binds to some big selection of endogenous opioids. Compared with most opioid receptors, this receptor functions being a scavenger https://richardb924mel0.wikipowell.com/user